SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060340
Filing Date
2023-11-07
Accepted
2023-11-07 16:40:31
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-20230930.htm   iXBRL 10-Q 2483848
2 EX-31.1 snse-ex31_1.htm EX-31.1 17687
3 EX-31.2 snse-ex31_2.htm EX-31.2 17936
4 EX-32.1 snse-ex32_1.htm EX-32.1 10682
  Complete submission text file 0000950170-23-060340.txt   9014226

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snse-20230930_pre.xml EX-101.PRE 362327
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snse-20230930_cal.xml EX-101.CAL 54815
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snse-20230930_def.xml EX-101.DEF 220917
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snse-20230930.xsd EX-101.SCH 58068
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snse-20230930_lab.xml EX-101.LAB 480646
68 EXTRACTED XBRL INSTANCE DOCUMENT snse-20230930_htm.xml XML 1503013
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 231384577
SIC: 2834 Pharmaceutical Preparations